You are viewing: China Biopreservation Market analysis
Part of: Biopreservation Market (Global)

The China Biopreservation Market was valued at $227.6 Million in 2024 and projected to reach to $391.3 Million by 2029, representing a compound annual growth rate of 11.4%. China's biopreservation market is positioned for sustained growth driven by increasing investments in regenerative medicine, cell therapy research, and advanced tissue banking capabilities.

China Biopreservation Market (2024-2029) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

China Biopreservation Market Trends and Insights

  • This growth trajectory reflects China's increasing investment in regenerative medicine, cell therapy, and advanced tissue banking infrastructure.
  • China's biopreservation sector is driven by rising demand for cryopreservation solutions across clinical and research applications, supported by government initiatives promoting biotechnology innovation and healthcare modernization. The 11.4% compound annual growth rate (CAGR) positions China as a high-growth market within the Asia Pacific region.
  • China's biopreservation expansion is fueled by growing adoption of stem cell therapies, expanding pharmaceutical R&D capabilities, and strengthening regulatory frameworks for cell and gene therapy.
  • Between 2024 and 2029, China is expected to consolidate its position as a leading biopreservation hub, driven by increased healthcare spending, technological advancement, and collaboration between academic institutions and commercial entities. China's market maturation reflects broader trends in personalized medicine and precision healthcare.
  • China continues to attract significant investment in biopreservation infrastructure, positioning the country as a critical market for global and domestic biopreservation solution providers..

Key Market Statistics

  • CAGR (2024-2029) 11.4% CAGR
  • Market Size, 2024 ~USD 227.6 Million
  • Forecast, 2029 ~USD 391.3 Million
  • Country China

China Biopreservation Market Overview

Market Valuation Growth :

China's biopreservation market is valued at USD 227.6 million in 2024, with a projected CAGR of 11.4% through 2029, reaching USD 391.3 million. This outpaces the global CAGR of 9.8%, positioning China as a high-growth market.

Regenerative Medicine Expansion :

China's investment in regenerative medicine and cell therapy is accelerating biopreservation adoption. Government support for stem cell research and tissue engineering initiatives is driving demand for advanced cryopreservation infrastructure.

Clinical & Banking Infrastructure :

Rising demand for cryopreservation solutions across clinical applications and tissue banking facilities reflects China's modernization of healthcare infrastructure and increased focus on personalized medicine and cell-based therapies.

Strategic Healthcare Investment :

China's healthcare sector modernization and biotechnology initiatives are creating favorable conditions for biopreservation technology adoption, supported by both public funding and private sector participation in advanced medical solutions.

China Biopreservation Market Dynamics

  • The country's emphasis on biotechnology innovation and healthcare modernization creates significant opportunities for cryopreservation solutions across clinical, research, and banking applications.
  • Government support for stem cell research and personalized medicine initiatives further accelerates market expansion.
  • By 2029, the market is expected to nearly double in value, reflecting China's commitment to becoming a global leader in advanced biomedical technologies and regenerative medicine applications..

Related Ecosystem

Biotechnology

Top Technologies
  • Reagents
  • Polymerase Chain Reaction (PCR)
  • Stem Cells
  • Assay Kits
  • Flow Cytometers
Top Companies
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Danaher Corporation
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.

    Key Takeaways

    • China's biopreservation market is valued at USD 227.6 million in 2024 and is forecast to grow to USD 391.3 million by 2029, representing an 11.4% CAGR.
    • China's market growth is driven by expanding stem cell therapy adoption, regenerative medicine initiatives, and government support for biotechnology innovation.
    • China's regulatory environment is strengthening for cell and gene therapies, creating favorable conditions for biopreservation solution deployment.
    • China's biopreservation sector is attracting significant domestic and international investment, positioning the country as a critical Asia Pacific growth engine.

    Biopreservation Market Report Scope

    Report Metric Details
    Base Year 2024
    Fastest Growing Segment BIOPRESERVATION EQUIPMENT (Product)
    Forecast Period 2024-2029
    Growth Rate CAGR of 9.8% from 2024 to 2029
    Largest Segment BIOPRESERVATION MEDIA (Product)
    Market Size Base Year (Billions) ~USD 4.45 (2024)
    Revenue Forecast (Billions) ~USD 7.1 (2029)
    Segments Covered Product, Type, Biospecimen, Application, End User, Transplant Type

    China Biopreservation Market Report Segmentation

    6 segment dimensions are covered across the global market.

    By Product

    • Biopreservation Accessories
    • Biopreservation Equipment
    • Biopreservation Media

    By Type

    • Alarm Monitoring Systems
    • Centrifuges
    • Cryogenic Storage Systems
    • Cryopreservation Media
    • Freezers
    • Hypothermic Preservation Media
    • Incubators
    • Other Biopreservation Equipment
    • Other Equipment
    • Refrigerators
    • Temperature Control Systems
    • Thawing Equipment

    By Biospecimen

    • Human Tissue Samples
    • Organs
    • Other Biospecimens
    • Stem Cells

    By Application

    • Other Applications
    • Research Applications
    • Therapeutic Applications

    By End User

    • Biobanks
    • Gene Banks
    • Hospitals
    • Other End Users

    By Transplant Type

    • Cord Blood Transplants
    • Organ Transplants

    CHINA: BIOPRESERVATION MARKET, BY END USER, 2022–2029

    Segment20222023202420252026202720282029CAGR (%)
    BIOBANKS114.4130146.6165.3185.7208.8237.3267.312.8
    GENE BANKS879810912113515116818911.6
    HOSPITALS12013515016718620723125811.5
    OTHER END USERS5158647179889710911.2
    TOTAL372.4421469.6524.3585.7654.8733.3823.311.9

    Target Audience

    • Biopreservation Technology Providers : Companies developing cryopreservation equipment and solutions need China-specific market data to identify growth opportunities, understand regulatory requirements, and develop localized product strategies.
    • Healthcare & Biotech Investors : Investment firms and venture capitalists require detailed market analysis of China's biopreservation sector to evaluate portfolio opportunities and assess growth potential in regenerative medicine and cell therapy.
    • Pharmaceutical & Biotech Companies : Organizations developing cell therapies and regenerative medicine products need insights into China's biopreservation infrastructure and market demand to support clinical development and commercialization strategies.
    • Hospital & Research Institution Administrators : Healthcare facility leaders and research directors require market intelligence to justify biopreservation infrastructure investments, benchmark against industry standards, and plan tissue banking expansion.
    • Government & Policy Makers : Healthcare policy officials and government agencies need comprehensive market data to inform biotechnology investment decisions, regulatory frameworks, and strategic initiatives supporting China's biomedical innovation goals.

    Reasons to Buy this Report

    • High-Growth Market Opportunity : With an 11.4% CAGR significantly exceeding global growth rates, China's biopreservation market offers exceptional investment and expansion opportunities for companies targeting emerging healthcare markets.
    • Government-Backed Growth Drivers : Strategic government support for regenerative medicine and biotechnology initiatives ensures sustained demand for biopreservation solutions, reducing market volatility and supporting long-term business planning.
    • Infrastructure Development Insights : Detailed analysis of China's expanding tissue banking and clinical cryopreservation infrastructure reveals specific entry points and partnership opportunities for biopreservation technology providers.
    • Competitive Landscape Intelligence : Comprehensive understanding of China's biopreservation sector dynamics, local competitors, and market positioning enables informed strategic decisions for market entry and competitive differentiation.
    • Forecast-Driven Planning : Reliable market projections through 2029 provide essential data for resource allocation, product development roadmaps, and revenue forecasting in China's rapidly evolving biopreservation sector.

    Frequently asked questions

    What is the current size of China's biopreservation market?

    China's biopreservation market was valued at USD 227.6 million in 2024 and is projected to reach USD 391.3 million by 2029.

    What is the growth rate of China's biopreservation market?

    China's biopreservation market is growing at a compound annual growth rate (CAGR) of 11.4% from 2024 to 2029.

    What are the primary drivers of growth in China's biopreservation market?

    China's biopreservation market growth is driven by increasing adoption of stem cell therapies, expanding regenerative medicine applications, government biotechnology initiatives, and strengthening regulatory frameworks for cell and gene therapies.

    Which applications are leading China's biopreservation market expansion?

    China's biopreservation market is led by applications in stem cell banking, tissue engineering, regenerative medicine, pharmaceutical R&D, and clinical cell therapy applications.

    How does China's biopreservation market compare to other Asia Pacific countries?

    China's 11.4% CAGR positions it as one of the fastest-growing biopreservation markets in Asia Pacific, reflecting strong government support, large patient populations, and significant investment in biotechnology infrastructure.

    RESEARCH METHODOLOGY

    The objective of the study is to analyze the key market dynamics, such as drivers, opportunities, challenges, restraints, and key player strategies. To track company developments such as acquisitions, product launches, expansions, collaborations, agreements, and partnerships of the leading players, the competitive landscape of the Biopreservation market to analyze market players on various parameters within the broad categories of business and product strategy. Top-down and bottom-up approaches were used to estimate the market size. To estimate the market size of segments and subsegments, the market breakdown and data triangulation were used.

    The four steps involved in estimating the market size are:

    Collecting Secondary Data

    The secondary research data collection process involves the usage of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B), annual reports, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Biopreservation market. A database of the key industry leaders was also prepared using secondary research.

    Collecting Primary Data

    The primary research data was conducted after acquiring knowledge about the Biopreservation market scenario through secondary research. A significant number of primary interviews were conducted with stakeholders from both the demand side (such as biobanks, gene banks, hospitals, and academic research institute) and supply side (such as included various industry experts, such as Directors, Chief X Officers (CXOs), Vice Presidents (VPs) from business development, marketing, and product development teams, product manufacturers, wholesalers, channel partners, and distributors) across major countries of North America, Europe, Asia Pacific, the Middle East & Africa, Latin America, and GCC. Approximately 40% of the primary interviews were conducted with stakeholders from the demand side, while those from the supply side accounted for the remaining 60%. Primary data for this report was collected through questionnaires, emails, and telephonic interviews.

    A breakdown of the primary respondents is provided below:

    Breakdown of Primary Participants:

    Biopreservation Market Size, and Share

    Note 1: *Others include sales managers, marketing managers, and product managers.

    Note 2: Tiers are defined based on a company’s total revenue as of 2023: Tier 1=> USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3=< USD 500 million.

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    All major product manufacturers offering various Biopreservation were identified at the global/regional level. Revenue mapping was done for the major players and was extrapolated to arrive at the global market value of each type of segment. The market value Biopreservation market was also split into various segments and subsegments at the region and country level based on:

    • Product mapping of various manufacturers for each type of Biopreservation market at the regional and country-level 
    • Relative adoption pattern of each Biopreservation market among key application segments at the regional and/or country-level 
    • Detailed primary research to gather qualitative and quantitative information related to segments and subsegments at the regional and/or country level. 
    • Detailed secondary research to gauge the prevailing market trends at the regional and/or country-level 

    Global Biopreservation Market Size: Top Down Approach

    Biopreservation Market Size, and Share

    To know about the assumptions considered for the study, Request for Free Sample Report

    Global Biopreservation Market Size: Bottom-Up Approach

    Biopreservation Market Size, and Share

    Data Triangulation

    After arriving at the overall market size—using the market size estimation processes—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the Biopreservation industry.

    Market Definition

    Biopreservation is a technique used for the storage of cells and tissues in a hypothermic or chemical environment to preserve biological samples with sustained integrity. The different types of biospecimen stored include human tissue samples, stem cells, and organs, which are majorly used in therapeutic and research applications. These high-yielding cell lines need to be preserved in order to provide optimum yield, viability, and productivity, which can be achieved by cryopreservation and vitrification in a hypothermic storage environment. Biopreservation is a rapidly emerging field of specimen procurement, processing, preservation and banking which requires a close collaboration between clinicians, engineers and scientists coming from academia, small private enterprises or huge industrial companies.

    Key Stakeholders

    • Senior Management
    • Finance/Procurement Department
    • Doctors/HCPs
    • Researchers
    • Lab Managers/Technicians
    • End Users/Operators

    Report Objectives

    • To provide detailed information about the factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
    • To define, describe, segment, and forecast the Biopreservation market by product, biospecimen, application, end user, and region.
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
    • To analyze micro markets with respect to individual growth trends, prospects, and contributions to the overall Biopreservation market
    • To forecast the size of the Biopreservation market in five main regions along with their respective key countries, namely, North America, Europe, the Asia Pacific, Latin America, Middle East & Africa, and GCC.
    • To profile key players in the Biopreservation market and comprehensively analyze their core competencies and market shares
    • To track and analyze competitive developments, such as acquisitions; product launches; expansions; collaborations, agreements, & partnerships; and R&D activities of the leading players in the Biopreservation market.
    • To benchmark players within the Biopreservation market using the Competitive Leadership Mapping framework, which analyzes market players on various parameters within the broad categories of business and product strategy

    Available Customizations

    MarketsandMarkets offers the following customizations for this market report:

    • Additional country-level analysis of the Biopreservation market
    • Profiling of additional market players (up to 5)

    Product Analysis

    • Product matrix, which provides a detailed comparison of the product portfolio of each company in the Biopreservation Market

    Get the Full Biopreservation Market Report

    Full forecast, segment splits, and company analysis for all Biopreservation Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status